Involvement of SMRT Corepressor in Transcriptional Repression by the Vitamin D Receptor
Overview
Molecular Biology
Authors
Affiliations
To repress the expression of target genes, the unliganded nuclear receptor generally recruits the silencing mediator of retinoid and thyroid hormone receptor (SMRT)/nuclear receptor corepressor via its direct association with the conserved motif within bipartite nuclear receptor-interaction domains (IDs) of the corepressor. Here, we investigated the involvement of the SMRT corepressor in transcriptional repression by the unliganded vitamin D receptor (VDR). Using small interference RNA against SMRT in human embryonic kidney 293 cells, we demonstrated that SMRT is involved in the repression of the VDR-target genes, osteocalcin and vitamin D(3) 24-hydroxylase in vivo. Consistent with this, VDR and SMRT are recruited to the vitamin D response element of the endogenous osteocalcin promoter in the absence of 1alpha,25-(OH)(2)D(3) in chromatin immunoprecipitation assays. To address the involvement of the VDR-specific interaction of SMRT in this repression, we identified the molecular determinants of the interaction between VDR and SMRT. Interestingly, VDR specifically interacts with ID1 of the SMRT/nuclear receptor corepressor and that ID1 is required for their stable interaction. We also identified specific residues in the SMRT-ID1 that are required for VDR binding, using the one- plus two-hybrid system, a novel genetic selection method for specific missense mutations that disrupt protein-protein interactions. These mutational studies revealed that VDR interaction requires a wide range of the residues within and outside the extended helix motif of SMRT-ID1. Notably, SMRT mutants defective in the VDR interaction were also defective in the repression of endogenous VDR-target genes, indicating that the SMRT corepressor is directly involved in the VDR-mediated repression in vivo via an ID1-specific interaction with the VDR.
Nuclear Receptor Coregulators in Hormone-Dependent Cancers.
Jafari H, Hussain S, Campbell M Cancers (Basel). 2022; 14(10).
PMID: 35626007 PMC: 9139824. DOI: 10.3390/cancers14102402.
VDR regulates simulated microgravity-induced atrophy in C2C12 myotubes.
Yuzawa R, Koike H, Manabe I, Oishi Y Sci Rep. 2022; 12(1):1377.
PMID: 35082348 PMC: 8791983. DOI: 10.1038/s41598-022-05354-0.
Developmental vitamin D deficiency increases foetal exposure to testosterone.
Ali A, Cui X, Pertile R, Li X, Medley G, Alexander S Mol Autism. 2020; 11(1):96.
PMID: 33298169 PMC: 7727109. DOI: 10.1186/s13229-020-00399-2.
Novel VDR antagonists based on the GW0742 scaffold.
Teske K, Bogart J, Arnold L Bioorg Med Chem Lett. 2017; 28(3):351-354.
PMID: 29287957 PMC: 6008168. DOI: 10.1016/j.bmcl.2017.12.041.
Vitamin D3 inhibits micro RNA-17-92 to promote specific immunotherapy in allergic rhinitis.
Yu Z, Zeng L, Luo X, Geng X, Xu R, Chen K Sci Rep. 2017; 7(1):546.
PMID: 28373650 PMC: 5428505. DOI: 10.1038/s41598-017-00431-1.